The differential effects of upadacitinib treatment on skin rashes of four anatomical sites in patients with atopic dermatitis

• Asıl Yazarlar: Teppei Hagino (Yazar), Hidehisa Saeki (Yazar), Eita Fujimoto (Yazar), Naoko Kanda (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Taylor & Francis Group, 2023-12-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background Upadacitinib is an oral Janus kinase (JAK) 1 inhibitor approved in Japan for moderate-to-severe atopic dermatitis (AD), and it provides a high therapeutic efficacy. Objectives We compared the therapeutic effects of upadacitinib on skin rashes of individual anatomical sites, head and neck,...